Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria. / Winther, Signe A.; Henriksen, Peter; Vogt, Josef K.; Hansen, Tue H.; Ahonen, Linda; Suvitaival, Tommi; Zobel, Emilie Hein; Frimodt-Møller, Marie; Hansen, Tine W.; Hansen, Torben; Parving, Hans-Henrik; Legido-Quigley, Cristina; Rossing, Peter; Pedersen, Oluf.
In: Diabetologia, Vol. 63, 2020, p. 2713-2724.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria
AU - Winther, Signe A.
AU - Henriksen, Peter
AU - Vogt, Josef K.
AU - Hansen, Tue H.
AU - Ahonen, Linda
AU - Suvitaival, Tommi
AU - Zobel, Emilie Hein
AU - Frimodt-Møller, Marie
AU - Hansen, Tine W.
AU - Hansen, Torben
AU - Parving, Hans-Henrik
AU - Legido-Quigley, Cristina
AU - Rossing, Peter
AU - Pedersen, Oluf
PY - 2020
Y1 - 2020
N2 - Aims/hypothesis Abnormal gut microbiota and blood metabolome profiles have been reported both in children and adults with uncomplicated type 1 diabetes as well as in adults with type 1 diabetes and advanced stages of diabetic nephropathy. In this study we aimed to investigate the gut microbiota and a panel of targeted plasma metabolites in individuals with type 1 diabetes of long duration without and with different levels of albuminuria.Methods In a cross-sectional study we included 161 individuals with type 1 diabetes and 50 healthy control individuals. Individuals with type 1 diabetes were categorised into three groups according to historically measured albuminuria: (1) normoalbuminuria (= 33.90 mg/mmol). From faecal samples, the gut microbiota composition at genus level was characterised by 16S rRNA gene amplicon sequencing and in plasma a targeted profile of 31 metabolites was analysed with ultra HPLC coupled to MS/MS.Results Study participants were aged 60 +/- 11 years (mean +/- SD) and 42% were women. The individuals with type 1 diabetes had had diabetes for a mean of 42 +/- 15 years and had an eGFR of 75 +/- 25 ml min(-1)(1.73 m)(-2). Measures of the gut microbial beta diversity differed significantly between healthy controls and individuals with type 1 diabetes, either with micro- or macroalbuminuria. Taxonomic analyses showed that 79 of 324 genera differed in relative abundance between individuals with type 1 diabetes and healthy controls and ten genera differed significantly among the three albuminuria groups with type 1 diabetes. For the measured plasma metabolites, 11 of 31 metabolites differed significantly between individuals with type 1 diabetes and healthy controls. When individuals with type 1 diabetes were stratified by the level of albuminuria, individuals with macroalbuminuria had higher plasma concentrations of indoxyl sulphate andl-citrulline than those with normo- or microalbuminuria and higher plasma levels of homocitrulline andl-kynurenine compared with individuals with normoalbuminuria. Whereas plasma concentrations of tryptophan were lower in individuals with macroalbuminuria compared with those with normoalbuminuria.Conclusions/interpretation We demonstrate that individuals with type 1 diabetes of long duration are characterised by aberrant profiles of gut microbiota and plasma metabolites. Moreover, individuals with type 1 diabetes with initial stages of diabetic nephropathy show different gut microbiota and plasma metabolite profiles depending on the level of albuminuria.
AB - Aims/hypothesis Abnormal gut microbiota and blood metabolome profiles have been reported both in children and adults with uncomplicated type 1 diabetes as well as in adults with type 1 diabetes and advanced stages of diabetic nephropathy. In this study we aimed to investigate the gut microbiota and a panel of targeted plasma metabolites in individuals with type 1 diabetes of long duration without and with different levels of albuminuria.Methods In a cross-sectional study we included 161 individuals with type 1 diabetes and 50 healthy control individuals. Individuals with type 1 diabetes were categorised into three groups according to historically measured albuminuria: (1) normoalbuminuria (= 33.90 mg/mmol). From faecal samples, the gut microbiota composition at genus level was characterised by 16S rRNA gene amplicon sequencing and in plasma a targeted profile of 31 metabolites was analysed with ultra HPLC coupled to MS/MS.Results Study participants were aged 60 +/- 11 years (mean +/- SD) and 42% were women. The individuals with type 1 diabetes had had diabetes for a mean of 42 +/- 15 years and had an eGFR of 75 +/- 25 ml min(-1)(1.73 m)(-2). Measures of the gut microbial beta diversity differed significantly between healthy controls and individuals with type 1 diabetes, either with micro- or macroalbuminuria. Taxonomic analyses showed that 79 of 324 genera differed in relative abundance between individuals with type 1 diabetes and healthy controls and ten genera differed significantly among the three albuminuria groups with type 1 diabetes. For the measured plasma metabolites, 11 of 31 metabolites differed significantly between individuals with type 1 diabetes and healthy controls. When individuals with type 1 diabetes were stratified by the level of albuminuria, individuals with macroalbuminuria had higher plasma concentrations of indoxyl sulphate andl-citrulline than those with normo- or microalbuminuria and higher plasma levels of homocitrulline andl-kynurenine compared with individuals with normoalbuminuria. Whereas plasma concentrations of tryptophan were lower in individuals with macroalbuminuria compared with those with normoalbuminuria.Conclusions/interpretation We demonstrate that individuals with type 1 diabetes of long duration are characterised by aberrant profiles of gut microbiota and plasma metabolites. Moreover, individuals with type 1 diabetes with initial stages of diabetic nephropathy show different gut microbiota and plasma metabolite profiles depending on the level of albuminuria.
KW - 16S RNA sequencing
KW - Diabetes
KW - Diabetic kidney disease
KW - Diabetic nephropathy
KW - Gut microbiota
KW - Metabolome
KW - Plasma metabolome
KW - Renal complications
KW - Targeted metabolites
KW - Type 1 diabetes
KW - INDOXYL SULFATE
KW - KIDNEY-DISEASE
KW - INTESTINAL MICROBIOTA
U2 - 10.1007/s00125-020-05260-y
DO - 10.1007/s00125-020-05260-y
M3 - Journal article
C2 - 32886190
VL - 63
SP - 2713
EP - 2724
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
ER -
ID: 249860868